More from the article ...

... "As we mark the two-year anniversary of adult-use cannabis in Connecticut, we recognize the progress made toward fostering a safe, regulated way for adults to purchase cannabis in our communities," said Department of Consumer Protection Deputy Commissioner Shirley Skyers-Thomas.

But while there has been growth, some industry insiders say that it has not been as strong as it might have been. Sales of medical cannabis have decreased month-over-month, despite "medical preservation plans" every supplier was told to file.

The top for medical cannabis sales was three months after recreational cannabis began in March, 2023, when there were nearly $13 million in medical cannabis sales. In November, that number had dropped to below $7 million.

"The medical market is going to naturally die when adult use programs happen," said Rino Ferrarese, manager and partner at Affinity Grow, one of the few large-scale suppliers to open since recreational sales began two years ago. "You just naturally see there's this attrition from the medical program" to recreational.

Connecticut cannabis is not sold in a bubble. If a consumer can't find what they want in the shop down the block, they need only travel across the border to Massachusetts, Rhode Island, New York or New Jersey. There, a consumer might find cheaper cannabis, a better selection of products, a friendlier atmosphere, or all of the above. ...

@#1 ... Connecticut cannabis is not sold in a bubble. If a consumer can't find what they want in the shop down the block, they need only travel across the border to Massachusetts, Rhode Island, New York or New Jersey. ...